[1] | Venkatachalam V, Hendley JO and Willson DF (2011): The diagnostic dilemma ofventilator-associated pneumonia in critically ill children. Pediatr Crit Care Med; 12:286–296. |
[2] | Dudeck MA, Horan TC, Peterson KD, et al. (2013): Pollock DA, Edwards JR: National Healthcare, Safety Network report, data summary for, device-associated module. Am J Infect Control; 41:286–300. |
[3] | Awasthi S, Tahazzul M, Ambast A, Govil YC and Jain A (2013): Longer duration of mechanical ventilation was found to be associated with ventilator-associated pneumonia in children aged 1 month to 12 years in India. J Clin Epidemiol; 66(1):62-6. |
[4] | Tripathi S, Malik G K, Amita Jain A, et al. (2010): Study of Ventilator Associated Pneumonia in Neonatal Intensive Care Unit: characteristics, risk factors and outcome Internet Journal of Medical Update; 5(1):12-19. |
[5] | Cernada M, Aguar M, Brugada M, et al. (2013): Ventilator- associated pneumonia in newborn infants diagnosed with an invasive bronchoalveolar lavage technique: a prospective observational study. Pediatr Crit Care Med; 14: 55–61. |
[6] | Jakbrittu R and Boloor R (2012): Characterisation of aerobic bacteria isolated from endotracheal aspirate in adult patients suspected ventilator associated pneumonia in a tertiary care center in Mangalore. Saudi J Anaesth; 6(2): 115–119. |
[7] | Lorente JA and Marshall JC (2005): Neutralization of tumor necrosis factor in preclinical models of sepsis. Shock; 24 (Suppl 1):107-19. |
[8] | McDermott MF, Aksentijevich I, Galon J and McDermott EM et al., (1999): Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell; 97(1):133-44. |
[9] | Yagi H, Soto-Gutierrez A, Navarro-Alvarez N and Nahmias Y, et al. (2010): Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther; 18(10):1857-64. |
[10] | Centers for Disease Control and Prevention (2009): Criteria for defining nosocomial pneumonia. www.cdc.gov/ncidod/hip/NNIS/members/penumonia/Final/PneuCriteriaFinal.pdf (accessed January 17). |
[11] | Foglia E, Meier M and Elward A (2007): Ventilator-Associated Pneumonia in Neonatal and Pediatric Intensive Care Unit Patients. Clin Microbiol Rev; 20(3): 409–425. |
[12] | Koulenti D, Lisboa T, Brun-Buisson C, et al. (2009): Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med; 37:2360–8. |
[13] | Bassetti M, Taramasso L, Giacobbe DR and Pelosi P (2012): Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy. Expert Rev Anti Infect Ther; 10:585–96. |
[14] | Kontermann RE, Münkel S, Neumeyer J, et al. (2008): A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action. J Immunother; 31:225–34. |
[15] | Boomer JS, To K, Chang KC, Takasu O, et al. (2011): Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA; 306:2594–605. |
[16] | Pessoa-Silva CL, Richtmann R, Calil R, Santos RM, Costa ML, Frota AC and Wey SB (2004): Healthcare-associated infections among neonates in Brazil. Infect. Control Hosp. Epidemiol; 25:772-777. |
[17] | Afify M, AI-Zahrani S and Nouh MA (2012): Risk Factors for the Development of Ventilator – Associated Pneumonia in Critically-Ill Neonates. Journal of American Science; 8(1):461-466. |
[18] | Lee PL, Lee WT and Chen HL (2016): Ventilator-Associated Pneumonia in Low Birth Weight Neonates at a Neonatal Intensive Care Unit: A Retrospective Observational Study, Pediatrics and Neonatology, http://dx.doi.org/0.1016/j. |
[19] | Apisarnthanarak A, Hozmann-PazgalG, Hamvas A, et al. (2003): Ventilator associated pneumonia in extremely preterm neonates in neonatal intensive care unit: Characteristics, risk factors and outcomes. Pediatrics; 112: 1283-9. |
[20] | Mir ZH, Ali I, Qureshi OA and Wani GR (2015): Risk factors, pathogen profile and outcome of ventilator associated pneumonia in a Neonatal intensive care unit. International Journal of Contemporary Pediatrics; 2(1):17. |
[21] | Yuam TM, Chen L and Yu HM (2007): Risk factors and uli for ventilator-associated pneumonia in neonatal intensive care unit patients. J Perinat Med; 35: 334-8. |
[22] | Livigston DH (2000): Prevention of ventilator associated pneumonia. Am J Surg; 179:12-7. |
[23] | Nemat B and Habibi P (2015): Does Re-intubation Increased Risk of Ventilator- Associated Pneumonia (VAP) in Pediatric Intensive Care Unit Patients? J Pediatr; 3: 411-415. |
[24] | Deng C, Li X, Zou Y, et al. (2011): Risk factors and pathogen profile of ventilator-associated pneumonia in a neonatal intensive care unit in China Pediatr Int; 53(3):332–337. |
[25] | Badr MA, Ali YF, Albanna EA, et al. (2011): Ventilator associated pneumonia in critically-ill neonates admitted to neonatal intensive care unit, Zagazig University Hospitals. Iran J Pediatr; 21: 418–424. |
[26] | Memish ZA, Cunningham G, Oni GA and Djazmati W (2000): The incidence and risk factors of ventilator-associated pneumonia in a Riyadh hospital. Infect Control Hosp Epidemiol; 21(4):271-3. |
[27] | El-Ward AM, Warren DK and Fraser VJ (2002): Ventilator associated pneumonia in pediatric intensive care unit: Risk factor and outcomes. Pediatrics; 109(5): 758-64. |
[28] | Garland JS (2014): Ventilator-Associated Pneumonia in Neonates: An Update in neonates. Neoreviews is the official journal of the American Academy of Pediatrics. DOI: 10.1542/neo.15-6-225. |
[29] | Cernada M, Brugada M, Golombek S, et al. (2014): Ventilator associated pneumonia in neonatal patients: an update. Neonatology; 105(2):98–107. |
[30] | Afjeh SA, Sabzehei MK, Karimi A, et al. (2012): Surveillance of ventilator-associated pneumonia in a neonatal intensive care unit: characteristics, risk factors, and outcome. Arch Iran Med; 15: 567–571. |
[31] | Povoa P, Coelho L and Almeida E (2005): C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect J; 11:101-8. |
[32] | Fallahi M, Dasht AS, Naeempour N, Bassir M and Ghadamli P (2014): Ventilator-Associated Pneumonia in Hospitalized Newborns in a Neonatal Intensive Care Unit. Arch Pediatr Infect Dis; 2(3):e16514. |
[33] | Berthelot P, Grattard H, Patural A, et al. (2001): Nosocomial colonization of premature babies with Klebsiella in developing countries. Epidermiology J; 22:148-51. |
[34] | Yuan TM, Chen LH and Yu HM (2007): Risk factors and outcomes for ventilator-associated pneumonia in neonatal intensive care unit patients. J Perinat Med; 35: 334–338. |
[35] | Khattab AA, El-Lahony DM and Soliman WF (2014): Ventilator-associated pneumonia in the neonatal intensive care unit. Menoufia Medical Journal; 27:73–77. |
[36] | Afjeh SA, Sabzehei MK, Karimi A, et al. (2012): Surveillance of ventilator-associated pneumonia in a neonatal intensive care unit: characteristics, risk factors, and outcome. Arch Iran Med; 15: 567–571. |
[37] | Koksal N, Hacimustafaoglu M, Celebi S, et al. (2006): Nonbronchoscopic bronchoalveolar lavage for diagnosis of ventilator associated pneumonia in newborn. Turkish J Pediatr; 48:213-20. |
[38] | Petdachai W (2004): Ventilator associated pneumonia in newborn intensive care unit in Prachomklao Hospital Thailand. Southeast Asian Tropical Med Public Health J; 3:724-9. |
[39] | Wajant H, Pfizenmaier K and Scheurich P (2003): Tumor necrosis factor signaling. Cell Death Differ; 10: 45–65. |
[40] | Karin M and Lin A (2002): NF-kappaB at the crossroads of life and death. Nat Immunol; 3: 221–227. |
[41] | Evangelidou M, Tseveleki V, Vamvakas S and Probe L (2010): TNFRI is a positive T-cell costimulatory molecule important for the timing of cytokine responses. Immunology and Cell Biology; 88:586–595. |
[42] | Martin-Loeches L, Bos L D, Povoa P, et al. (2015): Tumor necrosis factor receptor 1 (TNFRI) for ventilator-associated pneumonia diagnosis by cytokine multiplex analysis. Intensive Care Medicine Experimental; 3:26. |